CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: dutasteride
Accession: CHEBI:521033
browse the term
Definition: An aza-steroid that is inasteride in which the tert-butyl group is replaced by a 2,5-bis(trifluoromethyl)phenyl group. A synthetic 4-azasteroid, dutasteride is a selective inhibitor of both the type 1 and type 2 isoforms of steroid 5alpha-reductase, an intracellular enzyme that converts testosterone to 5alpha-dihydrotestosterone. Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
Synonyms: exact_synonym: N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
related_synonym: (5alpha,17beta)-N-(2,5-bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; Formula=C27H30F6N2O2; InChI=1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1; InChIKey=JWJOTENAMICLJG-QWBYCMEYSA-N; SMILES=C=1C(N[C@]2([C@@](C1)(C)[C@]3(CC[C@@]4([C@](CC[C@]4([C@]3([H])CC2)[H])(C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F)[H])C)[H])[H])=O; alpha,alpha,alpha,alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide
alt_id: MESH:D000068538
xref: Beilstein:7401530; CAS:164656-23-9; DrugBank:DB01126; Drug_Central:973; KEGG:D03820
xref_mesh: MESH:D000068538
xref: Patent:WO9507927; Wikipedia:Dutasteride
G
Adi1
acireductone dioxygenase 1
decreases expression
ISO
Dutasteride results in decreased expression of ADI1 mRNA
CTD
PMID:20564326
NCBI chr 6:45,306,885...45,313,847
Ensembl chr 6:45,306,841...45,313,842
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression
ISO
Dutasteride results in increased expression of AKR1C1 mRNA
CTD
PMID:16806904
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
Dutasteride results in increased expression of AKR1C2 mRNA
CTD
PMID:16806904
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
increases expression
ISO
Dutasteride results in increased expression of AKR1C3 mRNA
CTD
PMID:16806904
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Ar
androgen receptor
increases expression multiple interactions
ISO
Dutasteride results in increased expression of AR mRNA [Goserelin co-treated with Dutasteride co-treated with bicalutamide co-treated with Ketoconazole] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide] results in decreased expression of AR protein; [Goserelin co-treated with Dutasteride] results in decreased expression of AR protein
CTD
PMID:17636412 PMID:24323034
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Calr
calreticulin
multiple interactions decreases expression
ISO
Dutasteride promotes the reaction [Testosterone results in increased expression of CALR mRNA] Dutasteride results in decreased expression of CALR mRNA
CTD
PMID:20564326
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Ccnd1
cyclin D1
increases expression
ISO
Dutasteride results in increased expression of CCND1 mRNA
CTD
PMID:17636412
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cyp11b3
cytochrome P450, family 11, subfamily b, polypeptide 3
increases expression
ISO
Dutasteride results in increased expression of CYP11B2 mRNA
CTD
PMID:17636412
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
G
Dhcr24
24-dehydrocholesterol reductase
decreases expression
ISO
Dutasteride results in decreased expression of DHCR24 mRNA
CTD
PMID:17636412
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
G
Eaf2
ELL associated factor 2
multiple interactions decreases expression
ISO
Dutasteride promotes the reaction [Testosterone results in increased expression of EAF2 mRNA] Dutasteride results in decreased expression of EAF2 mRNA
CTD
PMID:20564326
NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610
G
Erbb2
erb-b2 receptor tyrosine kinase 2
increases expression
ISO
Dutasteride results in increased expression of ERBB2 mRNA
CTD
PMID:17636412
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Hsd17b1
hydroxysteroid (17-beta) dehydrogenase 1
increases expression
ISO
Dutasteride results in increased expression of HSD17B1 mRNA
CTD
PMID:17636412
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
G
Hsd17b3
hydroxysteroid (17-beta) dehydrogenase 3
increases expression
ISO
Dutasteride results in increased expression of HSD17B3 mRNA
CTD
PMID:17636412
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Dutasteride results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Klk1c10
kallikrein 1-related peptidase C10
decreases expression multiple interactions
ISO
Dutasteride results in decreased expression of KLK3 mRNA [Goserelin co-treated with Dutasteride co-treated with bicalutamide co-treated with Ketoconazole] results in decreased expression of KLK3 protein; [Goserelin co-treated with Dutasteride co-treated with bicalutamide] results in decreased expression of KLK3 protein; [Goserelin co-treated with Dutasteride] results in decreased expression of KLK3 protein
CTD
PMID:17636412 PMID:20564326 PMID:24323034
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
G
Sos1
SOS Ras/Rac guanine nucleotide exchange factor 1
increases expression
ISO
Dutasteride results in increased expression of SOS1 mRNA
CTD
PMID:17636412
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
G
Srd5a1
steroid 5 alpha-reductase 1
decreases expression decreases activity
ISO
Dutasteride results in decreased expression of SRD5A1 mRNA Dutasteride results in decreased activity of SRD5A1 protein
CTD
PMID:16806904
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
G
Srd5a2
steroid 5 alpha-reductase 2
decreases expression
ISO
Dutasteride results in decreased expression of SRD5A2 mRNA
CTD
PMID:16806904
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
G
Vcam1
vascular cell adhesion molecule 1
increases expression
ISO
Dutasteride results in increased expression of VCAM1 mRNA
CTD
PMID:17636412
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all